LEA LEIV 4
4 · Corvus Pharmaceuticals, Inc. · Filed Aug 15, 2022
Insider Transaction Report
Form 4
LEA LEIV
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-08-11+160,000→ 160,000 totalExercise: $0.96Exp: 2032-08-11→ Common Stock (160,000 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from August 11, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.